Alemtuzumab and Infections
Result of checking the interaction of drug Alemtuzumab and disease Infections for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Alemtuzumab should be used with caution in patients at risk of opportunistic infections, as therapy could result in severe and prolonged lymphopenia. It is recommended to administer prophylaxis against Pneumocystis jiroveci pneumonia (PCP) and herpes viral during and for a minimum of 2 months after completion of therapy or until the CD4+ count is >=200 cells/µL. Routinely monitor patients for CMV infection during therapy and withhold therapy for serious infections and during antiviral treatment for CMV infection or confirmed CMV viremia.
Generic Name: alemtuzumab
Brand Name: Campath, Lemtrada
Synonyms: n.a.
Alemtuzumab - infekcje 
Alemtuzumab - infecções 
Alemtuzumab - jangkitan 
Alemtuzumab - infeksi 
Alemtuzumab - infezioni 
Alemtuzumab - infections 
Alemtuzumab - Infektionen 
Alemtuzumab - infecciones 
Alemtuzumab - инфекции 
Alemtuzumab - enfeksiyonlar 
Alemtuzumab - الالتهابات 
Alemtuzumab - 感染